Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for Banamine® Transdermal (flunixin transdermal solution)

The only pour-on NSAID for cattle is now approved for control of fever due to mastitis MADISON, N.J., FEB. 15, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the U.S. Food and Drug … Continue reading Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for Banamine® Transdermal (flunixin transdermal solution)